1 For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions you might have prior to each time LEMTRADA (alemtuzumab) is given to you. Keep this guide for important safety information about the serious risks and reactions of LEMTRADA. Healthcare Providers: Review this patient guide with your patient prior to each treatment course, and provide your patient a copy to take home.
2 What Is LEMTRADA? LEMTRADA is a prescription medicine approved to treat adult patients with relapsing forms of multiple sclerosis. Because of serious risks with LEMTRADA, it is generally reserved for patients that have not been helped enough by 2 or more MS treatments. You and your healthcare provider have determined that LEMTRADA is an appropriate treatment for you. LEMTRADA is only available at your doctor s office, clinic, or hospital. It is not a medicine you will give yourself at home because of the serious risks of LEMTRADA. What Is the Most Serious Risk Information About LEMTRADA Treatment? LEMTRADA may cause serious side effects, including infusion reactions, autoimmune conditions, and malignancy. Most patients treated with LEMTRADA will experience side effects at the time of the infusion or within 24 hours after the infusion (infusion reactions). Common infusion reactions include nausea, hives, itching, difficulty sleeping, chills, flushing, fatigue, shortness of breath, congestion of the lungs, upset stomach, dizziness, and pain. Patients receiving LEMTRADA are at risk of autoimmune conditions. Your body s immune system contains particular cells that help fight infections. Autoimmune side effects are illnesses that occur when these cells of the immune system fight against your own body. Receiving LEMTRADA may increase your chance of getting some kinds of cancers (malignancies), including thyroid cancer, skin cancer (melanoma), and blood cancers called lymphoproliferative disorders and lymphoma. Call your healthcare provider if you have the following symptoms that may be a sign of thyroid cancer: new lump swelling in your neck pain in the front of your neck hoarseness or other voice changes that do not go away trouble swallowing or breathing cough that is not caused by a cold You should have your skin checked before you start receiving LEMTRADA, and each year while you are receiving treatment, to monitor for symptoms of skin cancer. 1
3 What Are the Signs and Symptoms of Infusion Reactions and Autoimmune Conditions After LEMTRADA Treatment, and What Should I Do? INFUSION REACTIONS Most patients treated with LEMTRADA will experience side effects at the time of the infusion, some of which may be serious or life-threatening. Serious infusion reactions may happen while you receive LEMTRADA, or up to 24 hours or longer after you receive LEMTRADA. Tell your healthcare provider right away if you have any of the following symptoms of a serious infusion reaction during the infusion or after you have left the healthcare facility: swelling in your mouth or throat trouble breathing weakness fast, slow, or irregular heart beat chest pain rash In order to try to reduce these effects, your doctor will give you medication (corticosteroids) prior to the first 3 infusions of a treatment course. You may also be given other treatments before or after the infusion to try to reduce your chances of these reactions or to treat them after they happen. In addition, you will be observed during the infusion and for at least 2 hours after the infusion has been completed, or longer if your healthcare provider decides you need to stay longer. In case of serious reactions, it is possible that the infusion may be stopped. 2
4 DELAYED SIDE EFFECTS As mentioned previously, patients receiving LEMTRADA are at risk of certain autoimmune conditions. The autoimmune conditions include: Immune thrombocytopenia (ITP, or low platelets) Other blood disorders (including neutropenia, hemolytic anemia, and pancytopenia) Certain types of kidney diseases Thyroid disorders All of these conditions can be treated when identified early, but delaying treatment increases the risk of complications. This is why it is so important to recognize and immediately report any signs or symptoms of these conditions to your doctor. In the following pages, you will learn more about each of these side effects, including the signs and symptoms that you may experience and what to do if they happen. Immune Thrombocytopenia (ITP, or low platelets) ITP is a condition which results in a decrease in the number of platelets in the blood. ITP has been observed in approximately 2% of patients treated with LEMTRADA in MS clinical trials. Platelets are necessary for normal blood clotting. ITP can cause severe bleeding. If detected early, ITP is usually treatable, but if left untreated it may lead to serious health problems and possibly death. A blood test will help your doctor watch for changes in your platelet count in order to catch this side effect early. Therefore, your doctor will have your blood tested before starting LEMTRADA and on a monthly basis after your first infusion. The monthly testing must continue for 4 years after your last infusion, or longer if you have signs or symptoms of ITP. Importantly, ITP may also be detected by certain signs or symptoms that you need to be aware of. What are the signs and symptoms of ITP? Small, scattered spots on your skin that are red, pink, or purple Easy bruising Bleeding from a cut that is harder to stop Heavier, longer, or more frequent menstrual periods than normal. Bleeding between your menstrual periods could also be a sign of ITP Bleeding from your gums or nose that is new or takes longer than usual to stop Call your doctor immediately if you have any of these signs or symptoms. If you cannot reach your doctor, seek immediate medical attention. 3
5 These pictures show examples of spots and bruises caused by ITP. This is an example of a leg with scattered spots under the skin that are red, pink, or purple. They might look like pinpricks. It is important to note that the spots could occur anywhere on your body, not just on your leg. This is an example of arms with easy or excessive bruising. It is important to note bruises could occur anywhere on your body, not just on your arms. This is an example of spots due to bleeding under the tongue. It is important to note that this could occur anywhere in your mouth under the tongue, on the roof of your mouth, on your inner cheeks, on your tongue, or on your gums. Note: These pictures are only a guide in order to show examples of bruises or rashes. Images 2015 Genzyme Corporation. What if I develop ITP? It is best to identify and treat ITP as early as possible. That is why it is so important that you continue to have your monthly blood test and check for symptoms, which could detect a problem before you have symptoms. It is also important that you, your family members, and/or caregivers are watching for any of the signs or symptoms described in this guide. Delaying treatment of ITP raises the chance of more serious problems. If detected early, ITP is usually treatable. If you develop ITP, you and your doctor will decide which treatment is best for you. If you notice any of the signs or symptoms as described above, call your healthcare provider right away to report the symptoms. If you cannot reach your healthcare provider, seek immediate medical attention. Other blood disorders (including neutropenia, hemolytic anemia, and pancytopenia) LEMTRADA may cause a decrease in some types of blood cells. Symptoms may include weakness, dark urine, chest pain, yellowing of the skin or whites of your eyes (jaundice), or fast heartbeat. Your healthcare provider will do blood tests to check for low blood counts. 4
6 Kidney disorders (such as anti-glomerular basement membrane disease) LEMTRADA may cause a condition known as anti-glomerular basement membrane disease, or anti-gbm disease. Kidney disorders, including anti-gbm disease, have been observed in 0.3% (3 per 1000) patients treated with LEMTRADA in MS clinical trials. Anti-GBM disease is an autoimmune side effect that can result in severe damage to the kidneys. Anti-GBM disease can also damage the lungs, although this was not seen in clinical trials with LEMTRADA. If untreated it can cause kidney failure requiring chronic dialysis or transplant, and may lead to death. Most of the time, doctors can treat kidney problems. It is best to begin treatment as early as possible. A blood test and a urine test will help your doctor watch for signs of kidney disease to help catch this potential side effect early. Your doctor will have your blood and urine tested in the month before you start treatment with LEMTRADA, and on a monthly basis after your initial infusion. Your doctor will test your urine monthly, so if you are a woman, it is important to avoid urine testing during your menstrual period as this may give a false result. This testing will continue for 4 years after your last infusion, or longer if you have signs or symptoms of a kidney disorder. Importantly, anti-gbm disease can also be detected by certain signs and symptoms that you need to be aware of. What are the signs and symptoms of kidney problems or anti-gbm disease? Blood in the urine (red or tea-colored urine) Swelling in your legs or feet Coughing up blood What if I develop kidney problems? It is best to begin treatment as early as possible. It is important that you are familiar with the signs and symptoms of kidney problems and anti-gbm disease, and complete your regular laboratory tests (blood and urine tests). Kidney problems will almost always need treatment. If you notice any of the signs or symptoms as described above, call your doctor right away to report the symptoms. If you cannot reach your doctor, seek immediate medical attention. 5
7 Thyroid disorders The thyroid is a gland found in the lower part of the neck. This gland produces hormones that are important throughout your body. In some people, the immune system may mistakenly attack the cells of the thyroid gland (autoimmune thyroid condition), which affects its ability to make and control the level of hormones. LEMTRADA may cause development of thyroid disorders including: Overactive thyroid gland, or hyperthyroidism, when the thyroid produces too much hormone Underactive thyroid gland, or hypothyroidism, when the thyroid does not produce enough hormone An estimated 34% of patients experienced autoimmune thyroid disorders following treatment with LEMTRADA, in MS clinical trials. Your blood will be checked in the month before you start treatment with LEMTRADA, and every 3 months after your initial infusion, until 4 years after your last LEMTRADA infusion, or longer if you show signs or symptoms of a thyroid disorder. This blood test will help your doctor detect thyroid disorders early. What are the signs and symptoms of a thyroid disorder? Overactive thyroid, or hyperthyroidism Excessive sweating Unexplained weight loss Eye swelling Nervousness Underactive thyroid, or hypothyroidism Unexplained weight gain Feeling cold Worsening tiredness Newly occurring constipation Fast heartbeat 6
8 What if I develop a thyroid disorder? Tell your doctor if you experience these symptoms. Most of the time, thyroid disorders are manageable with treatment. Depending on the type of thyroid disorder, your doctor will decide which treatment is best for you. It will be important to follow your doctor s recommendations to be sure to benefit the most from your treatment. In some cases, you may have to take medication for the rest of your life for your thyroid disorder. In some situations, your thyroid may need to be removed. If you develop a thyroid disorder, it is very important that you are properly treated for it, especially if you become pregnant after using LEMTRADA. Having an untreated thyroid disorder could harm your unborn baby, or harm your baby after birth. IMPORTANT! Since all of these autoimmune conditions could occur long after you received a course of treatment with LEMTRADA, it is very important that you continue to have your monthly blood and urine tests (even if you are feeling well). You must continue to watch for signs and symptoms Do this for 4 years after your last LEMTRADA infusion Early detection and prompt treatment may give you the best opportunity for improvement Carry your LEMTRADA Patient Safety Information Card with you at all times and show it to any healthcare professionals who are providing you with treatment (including for non-ms conditions) or in the event of a medical emergency. These are NOT all the possible side effects of LEMTRADA. Refer to the LEMTRADA Medication Guide that you were given or talk to your doctor or nurse for medical advice about other side effects. 7
9 How Can I Detect the Delayed Side Effects from LEMTRADA? To check for the development of autoimmune conditions (previously described), you will have to be monitored monthly by having your blood and urine tested. Your doctor will order blood and urine tests in the month before you start LEMTRADA treatment, and these tests will continue each month for 4 years after your last LEMTRADA infusion. Monitoring may need to continue for longer if you have signs or symptoms of autoimmune conditions. Your doctor will check the results of these tests to see if you have developed any side effects. It is very important that you continue to have these tests for 4 years after your last LEMTRADA infusion, even if you are feeling well (no symptoms or side effects). Side effects may occur many months to years after your LEMTRADA infusion and may be (in rare cases) life-threatening, so it is very important that you continue to be checked and that you watch out for symptoms. This will help allow a problem to be detected and treatment to begin right away. This means that you commit to the monthly blood and urine laboratory tests, continuing for 4 years after your last infusion with LEMTRADA. You and your doctor will work together as a team to make sure you get these tests done, and to plan them around your normal activities. If you are a woman, it is also important to avoid urine testing during your menstrual period, as this may give a false result. To help you better understand the duration of the effects of LEMTRADA treatment and the length of required follow-up, please refer to the diagram below. Year 1 Year 2 Year 3 Year 4 Year 5 TREATMENT Course 1 Course 2 MONITORING Start blood and urine testing before treatment 8
10 The following table shows you which laboratory tests are done, when, and for how long. Test Blood tests Urine tests When? Before treatment starts and every month after treatment Before treatment starts and every month after treatment For how long? For 4 years after your last LEMTRADA infusion For 4 years after your last LEMTRADA infusion How Is LEMTRADA Given? You will receive LEMTRADA through an intravenous line in your vein (infusion). LEMTRADA is given in two treatment courses. Generally, you will receive LEMTRADA for 5 days for the first treatment course and then for 3 days approximately 1 year later (second treatment course). The infusion takes place in a healthcare facility or infusion center. It takes about 4 hours to receive a full dose each day, but can take longer if you have side effects (infusion reactions), in which case the infusion may need to be slowed down or stopped. In order to try to reduce some of these reactions, your doctor will give you medication (corticosteroids) prior to the first 3 infusions of a treatment course. You may also be given other treatments before, during, or after the infusion to try to avoid these reactions or to treat them once they happen. In addition, you will be observed during the infusion and for at least 2 hours after the infusion has been completed or longer if your healthcare provider decides you need to stay longer. In case of serious reactions, it is possible that the infusion may be stopped. Where Can I Get More Information on LEMTRADA? There is a LEMTRADA Medication Guide that your doctor or nurse will give you at the beginning of your treatment course. You can also find additional information at or call the LEMTRADA REMS Program at How Can I Reach My Doctors? To make it easier to contact your doctor(s) or your healthcare team, please fill in their telephone numbers and addresses in the chart below. Doctor/Healthcare Team Telephone Number Address 9
12 LEMTRADA and Genzyme are registered trademarks of Genzyme Corporation Genzyme Corporation, a Sanofi company. All rights reserved. US.MS.LEM v2
Patient Guide Important information for patients starting therapy with LEMTRADA (alemtuzumab) This medicinal product is subject to additional monitoring. This will allow quick identification of new safety
For Prescribers LEMTRADA REMS Education Program for Prescribers This education program includes information about: The LEMTRADA REMS Program requirements Serious risks of autoimmune conditions, infusion
MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate Read this Medication Guide before you start receiving mitoxantrone and each time you receive mitoxantrone. There may be new information.
Presenting the SUTENT Patient Call Center. Please see patient Medication Guide and full prescribing information attached. We re here to support you. Dealing with cancer is a journey. Along the way, you
Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment
MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and before each time you get a treatment of REMICADE. This
TREATMENT OVERVIEW REVLIMID (lenalidomide) is used with dexamethasone to treat patients with multiple myeloma (MM) REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL)
Patient Medication Guide Brochure 1 MEDICATION GUIDE TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking TASIGNA and each time you get a refill. There may be new
MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b) Read this Medication Guide before you start taking SYLATRON, and each time you get a refill. There may be new information. This Medication
Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer A Review of the Research for Parents and Caregivers Is This Information Right
Be a part of the treatment decision by asking questions QUESTIONS TO ASK MY DOCTOR FOR PATIENTS WITH ADVANCED STOMACH OR GASTROESOPHAGEAL JUNCTION (GEJ) CANCER CYRAMZA (ramucirumab) is used alone or in
Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or
MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are
Treating Chronic Hepatitis C A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have chronic hepatitis C.
Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR AFTER THE FIRST MONTH OF THERAPY Not an actual patient. CONSUMERS What is the
i InfoNEURO Montreal Neurological Hospital INFORMATION FOR PATIENTS Mitoxantrone For multiple sclerosis Centre universitaire de santé McGill McGill University Health Centre Collaborators: D. Lowden Clinical
MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation
News Release Intended for U.S. Media Only Bayer Receives FDA Approval for BETACONNECT First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment Whippany, N.J., September
Staying on Track with TB TUBERCULOSIS Medicine What s Inside: Read this brochure to learn about TB and what you can do to get healthy. Put it in a familiar place to pull out and read when you have questions.
Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Read this Medication Guide before you start taking EQUETRO and each time you get a refill. There may be new information. This
PATIENT EDUCATION patienteducation.osumc.edu What is Gemcitabine (jem-site-a been)? Gemcitabine is a chemotherapy medicine known as an anti-metabolite. Another name for this drug is Gemzar. This drug is
Anticoagulation in Atrial Fibrillation Patient information RSBAY013 Anticoag A5 V2.indd 1 21/02/2014 17:13 Introduction This leaflet will help you understand your new medicine. Your new medicine is commonly
Goiter Introduction The thyroid gland is located at the base of your neck. If the gland becomes abnormally enlarged, it is called a goiter. Goiters usually do not cause pain. But a large goiter could cause
1 For the Patient: GDP Other names: LYGDP G D P Gemcitabine Dexamethasone (taken by mouth) CISPlatin Uses: GDP is a drug treatment given for Non-Hodgkins and Hodgkin Lymphoma with the expectation of destroying
Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain This leaflet is offered as a guide to you and your family. You will find it useful
AUBAGIO Conversation Starter When you are choosing a multiple sclerosis (MS) treatment for the first time or are considering switching your MS therapy, there can be a lot to think about for both you and
Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction
Traditional Chinese For the Patient: Cetuximab Injection Other names: ERBITUX Cetuximab (se tux i mab) is a drug that is used to treat some types of cancer. It is a monoclonal antibody, a type of protein
PATIENT EDUCATION patienteducation.osumc.edu What is AC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Doxorubicin (Adriamycin
Chemotherapy What It Is, How It Helps What s in this guide If your doctor has told you that you have cancer, you may have a lot of questions. Can I be cured? What kinds of treatment would be best for me?
For the treatment of patients with multiple myeloma Your treatment calendar for VELCADE (bortezomib) VELCADE (bortezomib) is approved for the treatment of patients with multiple myeloma (a cancer of the
PATIENT EDUCATION patienteducation.osumc.edu TCH: Docetaxel, Carboplatin and Trastuzumab What is TCH? It is the short name for the drugs used for this chemotherapy treatment. The three drugs you will receive
FROM RELAPSE TO RELIEF Keeping track of your MS relapse symptoms record your experience. share with your doctor. Tracking your MS relapse symptoms No matter what MS relapse treatment you re on or considering,
PATIENT EDUCATION patienteducation.osumc.edu What is Paclitaxel (pak-li-tax-el) and how does it work? Paclitaxel is a chemotherapy drug known as an anti-microtubule inhibitor. Another name for this drug
UW MEDICINE PATIENT EDUCATION Xofigo Therapy For metastatic prostate cancer This handout explains how the drug Xofigo is used to treat metastatic prostate cancer. What is Xofigo? Xofigo is a radioactive
FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get
MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium) Read this Medication Guide before you start taking COUMADIN (warfarin sodium) and each time you get a refill. There may be new information. This
For the Patient: Paclitaxel injection Other names: TAXOL Paclitaxel (pak'' li tax' el) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell your
TREATMENT OVERVIEW REVLIMID (lenalidomide) is used with dexamethasone to treat patients with multiple myeloma (MM) REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL)
Bone Marrow or Blood Stem Cell Transplants in Children With Certain Rare Inherited Metabolic Diseases * A Review of the Research for Parents and Caregivers * Wolman Disease, Farber Disease, Niemann-Pick
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
MEDICATION GUIDE (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets Read this Medication Guide carefully before you start taking and each time you get a refill. There may
PATIENT EDUCATION patienteducation.osumc.edu What is TC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Docetaxel (Taxotere
Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental
National Drug Abuse Treatment Clinical Trials Network STOP SMOKING STUDY Should I Join? NATIONAL INSTITUTES OF HEALTH U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Introduction Many people who abuse drugs
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet
X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended
Contents Babies from Birth to Age 2... 2 Vaccines give parents the power... 2 Vaccines are recommended throughout our lives... 3 Talk to your doctor... 3 Vaccines are very safe... 3 Whooping Cough (Pertussis)...
VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?
Information about medicines for multiple sclerosis Information about medicines for multiple sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain
ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has
AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide) AC is a regimen or treatment plan that includes a combination of chemotherapy drugs that your doctor prescribed for the treatment of your cancer.
MEDICATION GUIDE AVONEX Interferon beta-1a (Including appendix with instructions for using AVONEX Vials) Please read this guide carefully before you start to use AVONEX (a-vuh-necks) and each time your
Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about
Dallas Neurosurgical and Spine Associates, P.A Patient Health History DOB: Date: Reason for your visit (Chief complaint): Past Medical History Please check corresponding box if you have ever had any of
PATIENT EDUCATION patienteducation.osumc.edu CMF: Cyclophosphamide, Methotrexate and Fluorouracil What is CMF? This is the short name for the drugs used for this chemotherapy treatment. The three drugs
Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain
Rifapentine (Priftin ) Rifapentine (RIF uh PEN teen) is the generic name for Priftin. This medicine is used to treat latent tuberculosis infection, or latent TBI. This is when the TB germ is in your body,
PNEUMOVAX 23 Pneumococcal Vaccine Single Dose Vial/Pre-filled Syringe What is in this leaflet This leaflet answers some common questions about PNEUMOVAX 23. It does not contain all the available information.
loving life YOUR GUIDE TO YOUR THYROID one THE THYROID two HYPOTHYROIDISM three HYPERTHYROIDISM four TREATING HYPERTHYROIDISM five THYROID NODULES AND GOITRES one THE THYROID What is the thyroid? The thyroid
Note to Healthcare Professionals: Please provide this guide to your patient or your patient s caregiver. What You Need to Know About Xenazine (tetrabenazine) Patient/Caregiver Counseling Guide This guide
PHARMACIST DETACH HERE AND GIVE TO PATIENT MEDICATION GUIDE HORIZANT (ho-ri' zant) (gabapentin enacarbil) Extended-Release Tablets Read this Medication Guide before you start taking HORIZANT and each time
For the Patient: Pazopanib tablets Other names: VOTRIENT Pazopanib (paz oh pa nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have
* Your NHL Journey RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) * Non-Hodgkin s Lymphoma Indications RITUXAN (rituximab) is indicated for the treatment of: Follicular CD20-positive
CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM is available in single use bottles of 20 ml, 50 ml, 100 ml and 200 ml. OCTAGAM contains
Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision
Idiopathic Thrombocytopenic Purpura Idiopathic thrombocytopenic purpura (ITP) is a bleeding condition in which the blood doesn't clot as it should. This is due to a low number of blood cell fragments called
THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL See page 12 for FREE* TRIAL OFFER *Limitations and restrictions apply. Actor portrayal AMPYRA (dalfampridine)
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
MEDICATION GUIDE VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection.
Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.
CHOP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cytoxan (cyclophosphamide) H: Adriamycin (hydroxy doxorubicin) O: vincristine (Oncovin ) P: Prednisone How Is This
PATIENT EDUCATION patienteducation.osumc.edu Emergency Care for Patients of The James Emergency Care During and After Treatment Here are guidelines about when and how to report problems that you may have
MEDICATION GUIDE INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Read this Medication Guide before you start taking INTRON A, and each time you get a refill. There may be new information. This
Produced 28.02.2011 Revision due 28.02.2013 Symptoms of Hodgkin lymphoma Lymphoma is a cancer of cells called lymphocytes. These cells are part of our immune system, which helps us to fight off infections.
Page 1 of 5 PROCEDURE FOR: MAP-certified staff and RN/LPN MAP-certified staff are to be trained in the use of epinephrine administration via pre-filled autoinjector devices(s) annually. Certified staff
EMA/614203/2010 EMEA/H/C/000165 EPAR summary for the public rituximab This is a summary of the European public assessment report (EPAR) for. It explains how the Committee for Medicinal Products for Human
Your consent to our cookies if you continue to use this website.